GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cga | increases abundance | EXP | | 6480464 | CTD | CGA protein results in increased abundance of Progesterone | PMID:21458522 PMID:21871944 | Cga | increases secretion | EXP | | 6480464 | CTD | CGA protein results in increased secretion of Progesterone | PMID:18401014 | Cga | multiple interactions | EXP | | 6480464 | CTD | [[3,4',5-trimethoxystilbene co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; [[resveratrol co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone; ADM protein inhibits the reaction [CGA protein results in increased secretion of Progesterone]; bifenthrin analog inhibits the reaction [CGA protein results in increased abundance of Progesterone] | PMID:18401014 PMID:19603415 PMID:21871944 | Cga | increases abundance | ISO | Cga (Mus musculus) | 6480464 | CTD | CGA protein results in increased abundance of Progesterone | PMID:11213355 PMID:12647776 PMID:27181934 | Cga | increases secretion | ISO | CGA (Homo sapiens) | 6480464 | CTD | CGA protein results in increased secretion of Progesterone | PMID:19228890 PMID:20610540 PMID:25016925 PMID:29366778 PMID:31132478 PMID:33638691 | Cga | multiple interactions | ISO | CGA (Homo sapiens) | 6480464 | CTD | [3,4',5-trimethoxystilbene co-treated with CGA protein] results in increased secretion of Progesterone; [CGA protein affects the secretion of Cyclic AMP] which results in increased secretion of Progesterone; [CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone; [CGA protein co-treated with FSHB protein] results in increased secretion of Progesterone; [Resveratrol analog co-treated with CGA protein] results in increased secretion of Progesterone; [Resveratrol co-treated with CGA protein] results in increased secretion of Progesterone; [T0901317 co-treated with fatostatin] promotes the reaction [CGA protein results in increased secretion of Progesterone]; ADM protein modified form inhibits the reaction [ADM protein inhibits the reaction [CGA protein results in increased secretion of Progesterone]]; butylbenzyl phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; CFL1 protein affects the reaction [CGA protein results in increased secretion of Progesterone]; DDT inhibits the reaction [CGA protein results in increased secretion of Progesterone]; decabromobiphenyl ether inhibits the reaction [CGA protein results in increased secretion of Progesterone]; Dibutyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; Diethylhexyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]; fatostatin promotes the reaction [CGA protein results in increased secretion of Progesterone]; T0901317 inhibits the reaction [[CGA protein co-treated with FSHB protein] results in increased abundance of Progesterone] | PMID:18401014 PMID:19228890 PMID:19603415 PMID:20610540 PMID:20926582 PMID:23071612 PMID:25016925 PMID:29366778 PMID:31132478 PMID:33638691 | Cga | multiple interactions | ISO | Cga (Mus musculus) | 6480464 | CTD | lead acetate inhibits the reaction [CGA protein results in increased abundance of Progesterone]; mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Progesterone] | PMID:11213355 PMID:12647776 PMID:27181934 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |